» Articles » PMID: 34692548

Habitat Imaging-Based F-FDG PET/CT Radiomics for the Preoperative Discrimination of Non-small Cell Lung Cancer and Benign Inflammatory Diseases

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Oct 25
PMID 34692548
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To propose and evaluate habitat imaging-based F-fluorodeoxyglucose (F-FDG) positron emission tomography/computed tomography (PET/CT) radiomics for preoperatively discriminating non-small cell lung cancer (NSCLC) and benign inflammatory diseases (BIDs).

Methods: Three hundred seventeen F-FDG PET/CT scans were acquired from patients who underwent aspiration biopsy or surgical resection. All volumes of interest (VOIs) were semiautomatically segmented. Each VOI was separated into variant subregions, namely, habitat imaging, based on our adapted clustering-based habitat generation method. Radiomics features were extracted from these subregions. Three feature selection methods and six classifiers were applied to construct the habitat imaging-based radiomics models for fivefold cross-validation. The radiomics models whose features extracted by conventional habitat-based methods and nonhabitat method were also constructed. For comparison, the performances were evaluated in the validation set in terms of the area under the receiver operating characteristic curve (AUC). Pairwise t-test was applied to test the significant improvement between the adapted habitat-based method and the conventional methods.

Results: A total of 1,858 radiomics features were extracted. After feature selection, habitat imaging-based F-FDG PET/CT radiomics models were constructed. The AUC of the adapted clustering-based habitat radiomics was 0.7270 ± 0.0147, which showed significantly improved discrimination performance compared to the conventional methods (p <.001). Furthermore, the combination of features extracted by our adaptive habitat imaging-based method and non-habitat method showed the best performance than the other combinations.

Conclusion: Habitat imaging-based F-FDG PET/CT radiomics shows potential as a biomarker for discriminating NSCLC and BIDs, which indicates that the microenvironmental variations in NSCLC and BID can be captured by PET/CT.

Citing Articles

Preoperatively Predicting PIT1 Expression in Pituitary Adenomas Using Habitat, Intra-tumoral and Peri-tumoral Radiomics Based on MRI.

Zang Y, Zheng F, Feng L, Shi X, Chen X J Imaging Inform Med. 2025; .

PMID: 39904941 DOI: 10.1007/s10278-024-01376-4.


Application and progress of non-invasive imaging in predicting lung invasive non-mucinous adenocarcinoma under the new IASLC grading guidelines.

Feng J, Shao X, Gao J, Ge X, Sun Y, Shi Y Insights Imaging. 2025; 16(1):4.

PMID: 39747759 PMC: 11695567. DOI: 10.1186/s13244-024-01877-4.


F-FDG PET/CT-based habitat radiomics combining stacking ensemble learning for predicting prognosis in hepatocellular carcinoma: a multi-center study.

Sui C, Su Q, Chen K, Tan R, Wang Z, Liu Z BMC Cancer. 2024; 24(1):1457.

PMID: 39604895 PMC: 11600565. DOI: 10.1186/s12885-024-13206-5.


Habitat-based CT radiomics enhances the ability to predict spread through air spaces in stage T1 invasive lung adenocarcinoma.

Peng X, Zhao H, Wu S, Jia D, Hu M, Guo B Front Oncol. 2024; 14:1436189.

PMID: 39464700 PMC: 11502297. DOI: 10.3389/fonc.2024.1436189.


MRI-based habitat imaging in cancer treatment: current technology, applications, and challenges.

Li S, Dai Y, Chen J, Yan F, Yang Y Cancer Imaging. 2024; 24(1):107.

PMID: 39148139 PMC: 11328409. DOI: 10.1186/s40644-024-00758-9.


References
1.
Gambhir S . Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer. 2002; 2(9):683-93. DOI: 10.1038/nrc882. View

2.
Wu J, Gensheimer M, Dong X, Rubin D, Napel S, Diehn M . Robust Intratumor Partitioning to Identify High-Risk Subregions in Lung Cancer: A Pilot Study. Int J Radiat Oncol Biol Phys. 2016; 95(5):1504-1512. PMC: 4969127. DOI: 10.1016/j.ijrobp.2016.03.018. View

3.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M . Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225-49. DOI: 10.3322/caac.20006. View

4.
Xu H, Lv W, Feng H, Du D, Yuan Q, Wang Q . Subregional Radiomics Analysis of PET/CT Imaging with Intratumor Partitioning: Application to Prognosis for Nasopharyngeal Carcinoma. Mol Imaging Biol. 2019; 22(5):1414-1426. DOI: 10.1007/s11307-019-01439-x. View

5.
Tan Z, Yang C, Zhang X, Zheng P, Shen W . Expression of glucose transporter 1 and prognosis in non-small cell lung cancer: a pooled analysis of 1665 patients. Oncotarget. 2017; 8(37):60954-60961. PMC: 5617397. DOI: 10.18632/oncotarget.17604. View